News related to Acular (Ketorolac Ophthalmic) and/or conditions it is approved for
Age-related macular degeneration may be delayed by exercise
Source: Eye Health / Blindness News From Medical News Today [2014.02.13]
Moderate aerobic exercise helps to preserve the structure and function of nerve cells in the retina after damage, researchers at the Emory Eye Center and the Atlanta VA Medical Center have found.The findings, from a study of an animal model of age-related macular degeneration, are the first to suggest that aerobic exercise can have a direct effect on retinal health and vision.
Source: MedicineNet Cataracts Specialty [2014.01.23]
Title: Macular Degeneration
Category: Diseases and Conditions
Created: 7/23/1999 6:05:00 PM
Last Editorial Review: 1/23/2014 12:00:00 AM
Jetrea Gets FDA Nod for Macular Adhesion
Source: MedPage Today Product Alert [2012.10.19]
WASHINGTON -- The FDA has approved ocriplasmin (Jetrea) as the first nonsurgical treatment for symptomatic vitreomacular adhesion.
'Miniature Telescope' for Eye Approved for Macular Degeneration
Source: MedicineNet Macular Degeneration (Age-Related Type) Specialty [2010.07.07]
Title: 'Miniature Telescope' for Eye Approved for Macular Degeneration
Category: Health News
Created: 7/6/2010 2:10:00 PM
Last Editorial Review: 7/7/2010
Sight-saving eye drops could replace injections
Source: Health News from Medical News Today [2014.03.07]
Drug treatments for diseases that cause blindness could be delivered by eye drops instead of uncomfortable and costly eye injections, say UK researchers. The team reports how it tested this innovation on animals in the nanotechnology journal Small.The breakthrough could make a huge difference to the millions of people worldwide who, like author Stephen King and actress Dame Judi Dench, suffer from blindness-causing diseases like age-related macular degeneration (AMD), which affects 20% of people over the age of 75.
New innovation could mean eye injections are a thing of the past
Source: Eye Health / Blindness News From Medical News Today [2014.03.06]
Drugs used to treat blindness-causing disorders could be successfully administered by eye drops rather than unpleasant and expensive eye injections, according to new research led by UCL scientists that could be a breakthrough for the millions worldwide suffering from age-related macular degeneration (AMD) and other eye disorders.
Ocriplasmin Injection Linked to Impaired Vision
Source: Medscape Ophthalmology Headlines [2014.03.04]
Two case reports add to previous reports and link ocriplasmin for the treatment of symptomatic vitreomacular adhesion with impaired vision and panretinal changes.
Medscape Medical News
Potential to restore light sensitivity in blindness
Source: Eye Health / Blindness News From Medical News Today [2014.02.21]
Progressive degeneration of photoreceptors - the rods and cones of the eyes - causes blinding diseases such as retinitis pigmentosa and age-related macular degeneration. While there are currently no available treatments to reverse this degeneration, a newly developed compound allows other cells in the eye to act like photoreceptors.
Ruboxistaurin (RBX) may reduce risk of vision loss in diabetics
Source: The Doctors Lounge - Endocrinology and Diabetes
Phase III trial demonstrates ruboxistaurin (RBX) may reduce the risk of vision loss especially in diabetic macular edema.